BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30789286)

  • 1. The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression.
    Papp M; Gruca P; Lason M; Niemczyk M; Willner P
    J Psychopharmacol; 2019 Jun; 33(6):748-756. PubMed ID: 30789286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar-Kyoto rats.
    Papp M; Gruca P; Lason M; Litwa E; Solecki W; Willner P
    J Psychopharmacol; 2020 Dec; 34(12):1418-1430. PubMed ID: 33200659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Litwa E; Niemczyk M; Tota-Glowczyk K; Willner P
    Psychopharmacology (Berl); 2017 Sep; 234(17):2571-2585. PubMed ID: 28567697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression.
    Papp M; Gruca P; Lason M; Tota-Glowczyk K; Niemczyk M; Litwa E; Willner P
    J Psychopharmacol; 2018 Oct; 32(10):1133-1140. PubMed ID: 30182787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
    Willner P; Gruca P; Lason M; Tota-Glowczyk K; Litwa E; Niemczyk M; Papp M
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):239-250. PubMed ID: 30204592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional lateralization in the prefrontal cortex of dopaminergic modulation of memory consolidation.
    Papp M; Gruca P; Lason M; Niemczyk M; Willner P
    Behav Pharmacol; 2019 Sep; 30(6):514-520. PubMed ID: 31033526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Screening of Wistar and Wistar-Kyoto Rats Exposed to Chronic Mild Stress and Deep Brain Stimulation of Prefrontal Cortex.
    Papp M; Gruca P; Faron-Górecka A; Kusmider M; Willner P
    Neuroscience; 2019 Dec; 423():66-75. PubMed ID: 31705885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optogenetic stimulation of transmission from prelimbic cortex to nucleus accumbens core overcomes resistance to venlafaxine in an animal model of treatment-resistant depression.
    Papp M; Gruca P; Litwa E; Lason M; Willner P
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Apr; 123():110715. PubMed ID: 36610613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
    Millan MJ; Girardon S; Monneyron S; Dekeyne A
    Neuropharmacology; 2000 Feb; 39(4):586-98. PubMed ID: 10728880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of New Approaches to Depression Treatment Using an Animal Model of Pharmacoresistant Depression.
    Zvozilova A; Bukatova S; Koprdova R; Mach M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dopamine receptor expression and anti-depressant response following deep brain stimulation of the medial forebrain bundle.
    Dandekar MP; Luse D; Hoffmann C; Cotton P; Peery T; Ruiz C; Hussey C; Giridharan VV; Soares JC; Quevedo J; Fenoy AJ
    J Affect Disord; 2017 Aug; 217():80-88. PubMed ID: 28395208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
    Chagas-Martinich L; Carey RJ; Carrera MP
    Pharmacol Biochem Behav; 2007 Mar; 86(3):441-8. PubMed ID: 17291574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats.
    Van den Buuse M
    Eur J Pharmacol; 1993 Oct; 243(2):169-77. PubMed ID: 8276066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response.
    Papp M; Gruca P; Lason M; Litwa E; Solecki W; Willner P
    J Psychopharmacol; 2021 Oct; 35(10):1253-1264. PubMed ID: 34617804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement.
    Parsons LH; Caine SB; Sokoloff P; Schwartz JC; Koob GF; Weiss F
    J Neurochem; 1996 Sep; 67(3):1078-89. PubMed ID: 8752115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.